Individualised drug therapy based on pharmacogenomics: focus on carboxylesterase 1 (CES1) Individuelle forskelle i omsætningen af lægemidler
Phase of Trial: Phase IV
Latest Information Update: 21 Sep 2013
At a glance
- Drugs Methylphenidate (Primary) ; Trandolapril (Primary) ; Enalapril
- Indications Atherosclerosis; Attention-deficit hyperactivity disorder; Heart failure; Hypertension; Myocardial infarction
- Focus Pharmacogenomic; Pharmacokinetics
- Acronyms INDICES-WP2
- 21 Sep 2013 Planned number of patients changed from 35 to 45 as reported by European Clinical Trials Database record.
- 08 Dec 2012 Additional drug 'enalapril' added as treatment arm as reported by European Clinical Trials Database record.
- 27 Feb 2012 New trial record